|
|
Kazuhiro Shigemoto, Sachiho Kubo, Naoki Maruyama, Naohito Hato, Hiroyuki Yamada, Chen Jie, Naoto Kobayashi, Katsumi Mominoki, Yasuhito Abe, Norifumi Ueda,, Seiji Matsuda
J Clin Invest. 2006;
116(4):1016
doi:10.1172/JCI21545
Abstract |
Full text
| PDF
| Supplemental material

M
uscle-specific kinase (MuSK) is critical for the synaptic clustering of nicotinic acetylcholine receptors (AChRs) and plays multiple roles in the organization and maintenance of neuromuscular junctions (NMJs). MuSK is activated by agrin, which is released from motoneurons, and induces AChR clustering at the postsynaptic membrane. Although autoantibodies against the ectodomain of MuSK have been found in a proportion of patients with generalized myasthenia gravis (MG), it is unclear whether MuSK autoantibodies are the causative agent of generalized MG. In the present study, rabbits immunized with MuSK ectodomain protein manifested MG-like muscle weakness with a reduction of AChR clustering at the NMJs. The autoantibodies activated MuSK and blocked AChR clustering induced by agrin or by mediators that do not activate MuSK. Thus MuSK autoantibodies rigorously inhibit AChR clustering mediated by multiple pathways, an outcome that broadens our general comprehension of the pathogenesis of MG.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(33)
| Title and authors |
Publication |
Year |
Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis
Shuuichi Mori, Shigeru Yamada, Sachiho Kubo, Jie Chen, Seiji Matsuda, Masachika Shudou, Naoki Maruyama, Kazuhiro Shigemoto
|
Journal of Neuroimmunology
|
2012 |
Passive and active immunization models of MuSK-Ab positive myasthenia: Electrophysiological evidence for pre and postsynaptic defects
Angela Vincent, Stuart Viegas, Leslie Jacobson, Patrick Waters, Judith Cossins, Saiju Jacob, M. Isabel Leite, Richard Webster
|
Experimental Neurology
|
2012 |
Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice
R. Klooster, J. J. Plomp, M. G. Huijbers, E. H. Niks, K. R. Straasheijm, F. J. Detmers, P. W. Hermans, K. Sleijpen, A. Verrips, M. Losen
|
Brain
|
2012 |
Clinical and biological heterogeneity of autoimmune myasthenia gravis
Jozsef Pal, Csilla Rozsa, Samuel Komoly, Zsolt Illes
|
Journal of Neuroimmunology
|
2011 |
Anti-musk antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts
Jeffrey T. Guptill, Donald B. Sanders, Amelia Evoli
|
Muscle Nerve
|
2011 |
Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice
Anna Rostedt Punga, Shuo Lin, Filippo Oliveri, Sarina Meinen, Markus A. Rüegg
|
Experimental Neurology
|
2011 |
Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis
Nikolaos Trakas, Paraskevi Zisimopoulou, Socrates J. Tzartos
|
Journal of Neuroimmunology
|
2011 |
B-Cell-Activating Factor and Autoimmune Myasthenia Gravis
Samia Ragheb, Robert P. Lisak
|
Autoimmune Diseases
|
2011 |
Antibodies against Muscle-Specific Kinase Impair Both Presynaptic and Postsynaptic Functions in a Murine Model of Myasthenia Gravis
Shuuichi Mori, Sachiho Kubo, Takuyu Akiyoshi, Shigeru Yamada, Tsuyoshi Miyazaki, Harumi Hotta, Junzo Desaki, Masahiko Kishi, Tetsuro Konishi, Yuri Nishino
|
Amer J Pathol
|
2011 |
The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases
Alina Sesarman, Gestur Vidarsson, Cassian Sitaru
|
Cell. Mol. Life Sci.
|
2010 |
|